298 related articles for article (PubMed ID: 29915572)
21. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
[TBL] [Abstract][Full Text] [Related]
22. Human Thy-1 induces secretion of matrix metalloproteinase-9 and CXCL8 from human neutrophils.
Saalbach A; Arnhold J; Lessig J; Simon JC; Anderegg U
Eur J Immunol; 2008 May; 38(5):1391-403. PubMed ID: 18389476
[TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix remodeling effects of serum amyloid A1 in the human amnion: Implications for fetal membrane rupture.
Wang YW; Wang WS; Wang LY; Bao YR; Lu JW; Lu Y; Zhang CY; Li WJ; Sun K; Ying H
Am J Reprod Immunol; 2019 Jan; 81(1):e13073. PubMed ID: 30461130
[TBL] [Abstract][Full Text] [Related]
24. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
[TBL] [Abstract][Full Text] [Related]
25. A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.
Martínez-Burgo B; Cobb SL; Pohl E; Kashanin D; Paul T; Kirby JA; Sheerin NS; Ali S
Immunology; 2019 Jun; 157(2):173-184. PubMed ID: 31013364
[TBL] [Abstract][Full Text] [Related]
26. Serum amyloid A1 recruits neutrophils to the invasive front of T1 colorectal cancers.
Yoshido A; Sudo G; Takasawa A; Aoki H; Kitajima H; Yamamoto E; Niinuma T; Harada T; Kubo T; Sasaki H; Ishiguro K; Yorozu A; Kai M; Katanuma A; Yamano HO; Osanai M; Nakase H; Suzuki H
J Gastroenterol Hepatol; 2023 Feb; 38(2):301-310. PubMed ID: 36345658
[TBL] [Abstract][Full Text] [Related]
27. Induction of pro-inflammatory genes by serum amyloid A1 in human amnion fibroblasts.
Li W; Wang W; Zuo R; Liu C; Shu Q; Ying H; Sun K
Sci Rep; 2017 Apr; 7(1):693. PubMed ID: 28386088
[TBL] [Abstract][Full Text] [Related]
28. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
Liepnieks JJ; Kluve-Beckerman B; Benson MD
Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice.
Vanheule V; Crijns H; Poosti F; Ruytinx P; Berghmans N; Gerlza T; Ronsse I; Pörtner N; Matthys P; Kungl AJ; Opdenakker G; Struyf S; Proost P
Clin Exp Allergy; 2018 Oct; 48(10):1333-1344. PubMed ID: 29978510
[TBL] [Abstract][Full Text] [Related]
30. Interaction between serum amyloid A and leukocytes - a possible role in the progression of vascular complications in diabetes.
Hatanaka E; Monteagudo PT; Marrocos MS; Campa A
Immunol Lett; 2007 Feb; 108(2):160-6. PubMed ID: 17267050
[TBL] [Abstract][Full Text] [Related]
31. The cytokine-serum amyloid A-chemokine network.
De Buck M; Gouwy M; Wang JM; Van Snick J; Proost P; Struyf S; Van Damme J
Cytokine Growth Factor Rev; 2016 Aug; 30():55-69. PubMed ID: 26794452
[TBL] [Abstract][Full Text] [Related]
32. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
[TBL] [Abstract][Full Text] [Related]
33. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts JP; De Loof A; Heremans H; Proost P; Van Damme J
J Immunol; 1999 Dec; 163(11):6155-63. PubMed ID: 10570306
[TBL] [Abstract][Full Text] [Related]
34. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.
Lu J; Yu Y; Zhu I; Cheng Y; Sun PD
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5189-94. PubMed ID: 24706838
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes.
Qiu Z; Dillen C; Hu J; Verbeke H; Struyf S; Van Damme J; Opdenakker G
Immunobiology; 2009; 214(9-10):835-42. PubMed ID: 19628296
[TBL] [Abstract][Full Text] [Related]
36. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells.
Lee HY; Kim MK; Park KS; Bae YH; Yun J; Park JI; Kwak JY; Bae YS
Biochem Biophys Res Commun; 2005 May; 330(3):989-98. PubMed ID: 15809093
[TBL] [Abstract][Full Text] [Related]
37. Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.
Wuyts A; Govaerts C; Struyf S; Lenaerts JP; Put W; Conings R; Proost P; Van Damme J
Eur J Biochem; 1999 Mar; 260(2):421-9. PubMed ID: 10095777
[TBL] [Abstract][Full Text] [Related]
38. Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase.
Vandooren J; Goeminne P; Boon L; Ugarte-Berzal E; Rybakin V; Proost P; Abu El-Asrar AM; Opdenakker G
Front Immunol; 2018; 9():1154. PubMed ID: 29892293
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization.
Starckx S; Van den Steen PE; Wuyts A; Van Damme J; Opdenakker G
Leuk Lymphoma; 2002 Feb; 43(2):233-41. PubMed ID: 11999552
[TBL] [Abstract][Full Text] [Related]
40. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
